RT Journal Article
T1 Prognostic Value of Procalcitonin and C-Reactive Protein in 1608 Critically Ill Patients with Severe Influenza Pneumonia.
A1 Carbonell, Raquel
A1 Moreno, Gerard
A1 Martín-Loeches, Ignacio
A1 Gomez-Bertomeu, Frederic
A1 Sarvisé, Carolina
A1 Gómez, Josep
A1 Bodí, María
A1 Díaz, Emili
A1 Papiol, Elisabeth
A1 Trefler, Sandra
A1 Nieto, Mercedes
A1 Estella, Angel
A1 Jiménez Herrera, María
A1 Vidal Cortés, Pablo
A1 Guardiola, Juan José
A1 Solé-Violán, Jordi
A1 Rodríguez, Alejandro
K1 C-Reactive protein
K1 Gram negative bacilli
K1 Gram-positive cocci
K1 mortality
K1 pneumonia
K1 procalcitonin
AB Background: Procalcitonin (PCT) and C-Reactive protein (CRP) are well-established sepsis biomarkers. The association of baseline PCT levels and mortality in pneumonia remains unclear, and we still do not know whether biomarkers levels could be related to the causative microorganism (GPC, GNB). The objective of this study is to address these issues. Methods: a retrospective observational cohort study was conducted in 184 Spanish ICUs (2009-2018). Results: 1608 patients with severe influenza pneumonia with PCT and CRP available levels on admission were included, 1186 with primary viral pneumonia (PVP) and 422 with bacterial Co-infection (BC). Those with BC presented higher PCT levels (4.25 [0.6-19.5] versus 0.6 [0.2-2.3]ng/mL) and CRP (36.7 [20.23-118] versus 28.05 [13.3-109]mg/dL) as compared to PVP (p
SN 2079-6382
YR 2021
FD 2021-03-26
LK https://hdl.handle.net/10668/25062
UL https://hdl.handle.net/10668/25062
LA en
DS RISalud
RD Apr 7, 2025